The FDA has handed Incyte a complete response letter for a label expansion of the company’s monoclonal antibody Zynyz over issues at a third-party manufacturing site in Indiana that was formerly owned by Catalent. …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844